NVO - Novo Nordisk Collaborates With India's Online Marketplace To Remove Unauthorized Wegovy Listings | Benzinga
IndiaMART, an online marketplace in India, has reportedly taken action to remove unauthorized listings of Novo Nordisk A/S's (NYSE: NVO) highly sought-after weight-loss drug Wegovy after engaging in discussions with the Danish pharmaceutical company earlier this month.
Numerous listings were removed after Novo Nordisk notified IndiaMART about sellers needing the trademark for Wegovy.
Novo Nordisk, the sole patent holder of semaglutide—the active component in Wegovy and Novo's diabetes medication Ozempic—has been combating ...